Forty51 Ventures
Forty51 Ventures is a venture capital fund investing in Europe, focused on Biotech and Healthcare. They write Pre-seed and Seed cheques. We hold 7 investments for them on record. 5 people are listed at the firm.
forty51ventures.com- Sectors
- BiotechHealthcare
- Geographies
- Europe
- Cheque size
- Not on record
What Forty51 Ventures invests in
Invests in early-stage European biotech companies with first-in-class potential, incubating locally and scaling globally.
People at Forty51 Ventures
5 named people on record.
- Martin Sternm•••••@forty51ventures.com
- Sascha Oliver Buchers•••••@forty51ventures.com
Contact addresses at Forty51 Ventures are partly hidden. Create a free account to see full addresses, a fit score against your own startup, and an outreach email written for this investor.
3 more people at Forty51 Ventures.
The first two are open to everyone. A free account opens the rest — their names, roles and full contact addresses. No card, no demo call.
Forty51 Ventures portfolio
7 investments on record. Each row says whether the round came from the fund's own portfolio page or from the press, so you can check it.
| Company | Sector | Round | Amount | Date |
|---|---|---|---|---|
| BiotechSwitzerland | — | — | Jan 2026their site | |
| Cartilla TherapeuticsPrevention of Post-traumatic Osteoarthitis (PTOA) | BiotechSwitzerland | — | — | Jan 2025their site |
5 more investments on record for Forty51 Ventures.
The first two are open to everyone. A free account opens the rest — the company, the round, the amount, the date and where each number came from. No card, no demo call.
Investors similar to Forty51 Ventures
Seventure PartnersInvests in innovative digital tech and life sciences companies, focusing on health,…
Spider CapitalSeed-stage investor backing applied AI software for industrial digital transformation,…
Or browse the whole directory.
Write to Forty51 Ventures with something they'll read.
Pitch2Fund scores your startup against Forty51 Ventures's actual thesis and portfolio, then writes the email — citing the companies they've already backed and why yours fits beside them. Free, and you keep the contacts.